Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
53
AMAT Quote, Financials, Valuation and Earnings
Last price:
$152.9700
Seasonality move
:
5.94%
Day range:
$153.8450 - $156.6400
52-week range:
$123.7365 - $255.8900
Dividend yield:
1.04%
P/E ratio:
20.21x
P/S ratio:
4.64x
P/B ratio:
6.74x
Volume:
4M
Avg. volume:
8.6M
1-year change:
-24.24%
Market cap:
$125.6B
Revenue:
$27.2B
EPS (TTM):
$7.65
Analysts' Opinion
-
Consensus RatingApplied Materials has received a consensus rating of Buy. The company's average rating is a Buy based on 21 Buy ratings, 10 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $201.7746, Applied Materials has an estimated upside of 30.51% from its current price of $154.6100.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $152.0000 representing 1.69% downside risk from its current price of $154.6100.
Fair Value
-
According to the consensus of 32 analysts, Applied Materials has 30.51% upside to fair value with a price target of $201.7746 per share.
AMAT vs. S&P 500
-
Over the past 5 trading days, Applied Materials has overperformed the S&P 500 by 1.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Applied Materials does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Applied Materials has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Applied Materials reported revenues of $7.2B.
Earnings Growth
-
Applied Materials earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Applied Materials reported earnings per share of $1.45.
Enterprise value:
123.7B
EV / Invested capital:
--
Price / LTM sales:
4.64x
EV / EBIT:
15.04x
EV / Revenue:
4.47x
PEG ratio (5yr expected):
3.47x
EV / Free cash flow:
20.84x
Price / Operating cash flow:
21.62x
Enterprise value / EBITDA:
14.34x
Gross Profit (TTM):
$13.2B
Return On Assets:
19.24%
Net Income Margin (TTM):
22.95%
Return On Equity:
34.44%
Return On Invested Capital:
26%
Operating Margin:
30.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $26.3B | $26.5B | $27.6B | $6.7B | $7.2B | |
| Gross Profit | $12.2B | $12.4B | $13.2B | $3.2B | $3.5B | |
| Operating Income | $7.8B | $7.7B | $8.1B | $2B | $2.2B | |
| EBITDA | $8.3B | $8.9B | $8.6B | $2.5B | $2.3B | |
| Diluted EPS | $7.46 | $8.50 | $7.65 | $2.41 | $1.45 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $14.3B | $15.7B | $16.7B | $19.2B | $20.7B | |
| Total Assets | $23.3B | $25.4B | $28B | $31.5B | $33.3B | |
| Current Liabilities | $4.5B | $6.3B | $7.3B | $7.1B | $7.7B | |
| Total Liabilities | $11.8B | $13.5B | $14.5B | $14.1B | $14.7B | |
| Total Equity | $11.5B | $11.9B | $13.4B | $17.4B | $18.6B | |
| Total Debt | $5.4B | $5.5B | $5.7B | $5.6B | $6.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5B | $8.8B | $7.3B | $2.3B | $925M | |
| Cash From Investing | -$1.5B | -$1.7B | -$2.8B | -$447M | -$897M | |
| Cash From Financing | -$5.2B | -$3.8B | -$5.1B | -$1.2B | -$1.8B | |
| Free Cash Flow | $4.1B | $7.7B | $5.9B | $2.1B | $544M | |
AMAT
Sector
Market Cap
$125.6B
$78.1M
Price % of 52-Week High
60.42%
58.31%
Dividend Yield
1.04%
0%
Shareholder Yield
3.61%
0.8%
1-Year Price Total Return
-24.24%
-16.75%
Beta (5-Year)
1.712
0.847
Dividend yield:
1.04%
Annualized payout:
$1.44
Payout ratio:
19.74%
Growth streak:
7 years
Technicals
8-day SMA
Buy
Level
$151.4300
200-day SMA
Sell
Level
$177.7867
Bollinger Bands (100)
Sell
Level
146.7546 - 177.9946
Chaikin Money Flow
Buy
Level
118.5M
20-day SMA
Buy
Level
$144.4613
Relative Strength Index (RSI14)
Buy
Level
57.4980
ADX Line
Buy
Level
14.9794
Williams %R
Sell
Level
-8.7257
50-day SMA
Buy
Level
$149.5621
MACD (12, 26)
Buy
Level
1.2103
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Sell
Level
-106.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.8441)
Buy
CA Score
(Annual)
Level (1.221)
Buy
Beneish M-Score
(Annual)
Level (-2.6402)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.1494)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Applied Materials Inc is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.
Stock Forecast FAQ
In the current month, AMAT has received 21 Buy ratings 10 Hold ratings, and 1 Sell ratings. The AMAT average analyst price target in the past 3 months is $201.7746.
-
Where Will Applied Materials Stock Be In 1 Year?
According to analysts, the consensus estimate is that Applied Materials share price will rise to $201.7746 per share over the next 12 months.
-
What Do Analysts Say About Applied Materials?
Analysts are divided on their view about Applied Materials share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Applied Materials is a Sell and believe this share price will drop from its current level to $152.0000.
-
What Is Applied Materials's Price Target?
The price target for Applied Materials over the next 1-year time period is forecast to be $201.7746 according to 32 Wall Street analysts, 21 of them rate the stock a Buy, 1 rates the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is AMAT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Applied Materials is a Buy. 21 of 32 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AMAT?
You can purchase shares of Applied Materials via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Applied Materials shares.
-
What Is The Applied Materials Share Price Today?
Applied Materials was last trading at $152.9700 per share. This represents the most recent stock quote for Applied Materials. Yesterday, Applied Materials closed at $154.6100 per share.
-
How To Buy Applied Materials Stock Online?
In order to purchase Applied Materials stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
